In addition, abnormalities in NRF2 localization and function, as well as genetic polymorphisms, have been reported in patients with vitiligo, further supporting a model of impaired NRF2–ARE signaling in disease pathogenesis [49,50]. The gene discussed is NFE2L2; the disease is vitiligo.